Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IDT AustraliaASX:IDT -2.13% Days Payable is 55.76 as of Jun. 2026, which is 34% below its 10-year median of 84.56. The stock has 5 warning signs investors should review. Among 925 Drug Manufacturers companies, IDT Australia ranks worse than 57.62% on this metric.
The historical data trend for IDT Australia's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, IDT Australia's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDT Australia Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IDT Australia's Days Payable distribution charts can be found below:
* The bar in red indicates where IDT Australia's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
IDT Australia's Days Payable for the fiscal year that ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDT Australia (ASX:IDT) has a Days Payable of 55.76 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on IDT Australia and its competitors. This is 34% below median its historical median of 84.56. Over the past decade, IDT Australia's Days Payable has ranged from 41.99 to 396.94. According to the industry distribution chart, IDT Australia ranks #533 out of 925 companies in the Drug Manufacturers industry, placing it in the top 57.6%.
Is IDT Australia's Days Payable too high?
IDT Australia's current Days Payable of 55.76 is 34% below median its 10-year median of 84.56. Over the past 10 years, this metric has ranged from a low of 41.99 to a high of 396.94. The Drug Manufacturers industry median Days Payable is 89.70. IDT Australia's value of 55.76 is 37.8% below this industry median. Based on the distribution chart, IDT Australia ranks #533 out of 925 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does IDT Australia's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, IDT Australia ranks #533 out of 925 companies for Days Payable. This places IDT Australia in the lower half of its industry. The industry median Days Payable is 89.70. IDT Australia's value of 55.76 is 37.8% below this benchmark. Historically, IDT Australia's own Days Payable has ranged from 41.99 to 396.94 over the past decade. While the company's 10-year median is 84.56 vs. the industry median of 89.70, IDT Australia has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 89.70, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IDT Australia's current Days Payable of 55.76 is 37.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on IDT Australia and its competitors. For the Drug Manufacturers industry, the median Days Payable is 89.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDT Australia's current Days Payable is 55.76, which is 34% below median its own 10-year median of 84.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDT Australia stock overvalued right now?
Based on GuruFocus' analysis, IDT Australia (ASX:IDT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.12, compared to a current price of A$0.05 — trading 61.7% below its estimated fair value. The current Days Payable is 55.76, which is 34% below median its 10-year median of 84.56 and 37.8% below the Drug Manufacturers industry median of 89.70. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For IDT Australia (ASX:IDT), the current Days Payable is 55.76 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services. The company operates in Australia, Asia, Europe, and the USA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:IDT has been successfully added to your 
